Table 1.

Summary of proposed targets of BIM compounds used as standards [41,59,65,68,69,70,71,72,73,74,75].

BIM	Proposed Targets
BIM-I	PKC, GSK-3β, 5-HT3, ABCG2, OCT-1, PDK1, MSK1, MAPKAP-K1, S6K1, Chk1, PKA, DYRK1
BIM-II	PKC, ABCG2, OCT-1, PDK1, MSK1, MAPKAP-K1, PKA, DYRK1
BIM-III	PKC, ABCG2, OCT-1, S6K1, MAPKAPK1, RSK2, MSK1, PDK1
BIM-IV	PKC, PKA, MAPKAPK1, MSK1, ABCG2
BIM-V	ABCG2, SK6
BIM-VI	OCT-1
BIM-VII	OCT-1
BIM-VIII	PKC, GSK-3β, carbachol-evoked noradrenaline release, OCT-1, PDK1, MSK1, S6K1, PKA, DYRK1, MAPKAPK1
BIM-IX	PKC, GSK-3β, MAPKAPK1, MSK1, OCT-1, S6K1
BIM-X	Multiple Protein Kinases
BIM-XI	PKC, T-cell activation